Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

Share Price is delayed by 15 minutes
Get Live Data
2,602.00    138.00 (5.60%)
Bid:
2,596.00
Ask:
2,598.00
Spread: 2.00 (0.077%)
Market Cap: £8.35b
BNZL Live PriceLast checked at - London Stock Exchange

Intraday Bunzl Share Chart

Trading Statement

21 Oct 2025 07:00

RNS Number : 0892E
Bunzl PLC
21 October 2025
 

21 October 2025

 

BUNZL Q3 TRADING STATEMENT

IN-LINE WITH EXPECTATIONS; FY GUIDANCE UNCHANGED

 

Bunzl plc, the specialist international distribution and services Group, today announces its trading statement for the period since 30 June 2025.

Group revenue in the quarter grew by 0.6% at constant exchange rates. Underlying revenue1, which is organic revenue adjusted for trading days, increased by 0.4%, in line with our expectations, against what remain challenging end markets in our key business areas. Net acquisitions2 contributed growth of 1.4% at constant exchange rates, while fewer trading days in the period impacted revenue by 1.1%. Overall, at actual exchange rates, Group revenue declined by 0.8%. In-line with expectations, the year-on-year operating margin decline over the quarter moderated compared to the first half of the year.

The Group's full year guidance remains unchanged. The Group continues to expect moderate revenue growth in 2025, at constant exchange rates, driven by announced acquisitions and broadly flat underlying revenue. Group operating margin for the year is expected to be moderately below 8.0%, compared to 8.3% in 2024, with a continued expectation for a moderation of year-on-year operating margin decline in the second half, compared to the first half.

We have now completed c.£190 million of our announced £200 million 2025 buyback. The Group continues to expect leverage to be just over, and towards, 2.0 times at the end of 2025, after potential acquisition spend and the completion of the buyback.

Commenting on today's announcement, Frank van Zanten, Chief Executive Officer of Bunzl, said:

"In what remains a challenging market, we remain strongly focused on improving performance across the business. As we enter the important final quarter, I am pleased to see the actions that we have taken driving operational improvements, as expected. We reiterate our Group outlook for 2025.

As highlighted in our recent investor seminar, we remain confident in the significant opportunities we see for continued acquisition growth. We have completed seven acquisitions year-to-date and our pipeline is active. I remain confident in the Group's underlying resilience and strength, and ability to deliver consistent compounding growth in the medium-term."

 

Enquiries:

Bunzl plc

Frank van Zanten, Chief Executive Officer

Richard Howes, Chief Financial Officer

Sunita Entwisle, Head of Investor Relations and Communications

Tel: +44 (0)20 7725 5000

 

Teneo

Martin Robinson

Kate Somerville

Tel: +44 (0)20 7353 4200

 

 

 

 

1. Growth in hyperinflationary economies was not in excess of 26% per annum.

2. Acquisition growth of 1.8%, net of a 0.4% reduction related to disposals.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBUBDGGUDDGUG
Date   Source Headline
1st Jul 20199:30 amRNSTotal Voting Rights
26th Jun 20197:00 amRNSTrading Statement
14th Jun 20195:30 pmRNSDirector/PDMR Shareholding
12th Jun 20195:15 pmRNSDirector/PDMR Shareholding
5th Jun 20191:00 pmRNSDirector/PDMR Shareholding
3rd Jun 20198:00 amRNSTotal Voting Rights
28th May 20197:00 amRNSDirectorate Change
21st May 20194:30 pmRNSDirector/PDMR Shareholding
21st May 20198:00 amRNSAdditional Listing
14th May 20198:00 amRNSAdditional Listing
10th May 20193:30 pmRNSHolding(s) in Company
10th May 20197:00 amRNSDirectorate Change
3rd May 20194:20 pmRNSDirector/PDMR Shareholding
1st May 20193:00 pmRNSBlock listing Interim Review
1st May 201910:20 amRNSTotal Voting Rights
18th Apr 20193:15 pmRNSHolding(s) in Company
17th Apr 20194:00 pmRNSResult of AGM
17th Apr 20197:00 amRNSTrading Statement
11th Apr 20195:25 pmRNSDirector/PDMR Shareholding
3rd Apr 20195:00 pmRNSDirector/PDMR Shareholding
1st Apr 20194:15 pmRNSDirector/PDMR Shareholding
1st Apr 20193:37 pmRNSHolding(s) in Company
1st Apr 20192:30 pmRNSTotal Voting Rights
29th Mar 201911:30 amRNSDirector/PDMR Shareholding
25th Mar 20192:37 pmRNSHolding(s) in Company
14th Mar 20194:40 pmRNSAnnual Financial Report
14th Mar 201912:30 pmRNSDirector/PDMR Shareholding
11th Mar 20195:30 pmRNSDirector/PDMR Shareholding
7th Mar 20195:00 pmRNSDirector/PDMR Shareholding
5th Mar 20194:30 pmRNSDirector/PDMR Shareholding
4th Mar 20195:45 pmRNSDirector/PDMR Shareholding
4th Mar 20195:45 pmRNSDirector/PDMR Shareholding
1st Mar 20193:00 pmRNSDirector/PDMR Shareholding
1st Mar 201911:00 amRNSTotal Voting Rights
25th Feb 201910:00 amRNSDividend Declaration
25th Feb 20197:00 amRNSFinal Results
25th Feb 20197:00 amRNSAcquisition
4th Feb 20196:00 pmRNSDirector/PDMR Shareholding
1st Feb 20199:00 amRNSTotal Voting Rights
9th Jan 20194:30 pmRNSDirector/PDMR Shareholding
3rd Jan 20195:15 pmRNSDirector/PDMR Shareholding
3rd Jan 20197:00 amRNSTotal Voting Rights
13th Dec 20187:00 amRNSTrading Statement
6th Dec 201810:00 amRNSDirector/PDMR Shareholding
6th Dec 20187:00 amRNSDirectorate Change
4th Dec 20184:15 pmRNSDirector/PDMR Shareholding
4th Dec 201812:15 pmRNSDirector/PDMR Shareholding
3rd Dec 20187:00 amRNSTotal Voting Rights
28th Nov 20184:50 pmRNSDirector/PDMR Shareholding
26th Nov 20188:00 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.